Will Rua Bioscience spark more NZX cannabis entrants?

Will Rua Bioscience spark more NZX cannabis entrants?
Brent Melville
Rua Bioscience was trading at 69 cents from its 50 cent listing price within a few hours of becoming the first NZX public listing of the year.The second medicinal cannabis company after Cannasouth to head to the NZX had raised $20 million in its initial public offering earlier this week.The oversubscribed IPO saw 10 million of the 40 million shares allocated through a priority offer to Tairāwhiti residents and Waiapu Investments shareholders.Lead manager Northington Partners reported about 86 percent of those applicants had received their share...